Survival results from a phase III study of simultaneous versus 1-hour sequential methotrexate-5-fluorouracil chemotherapy in head and neck cancer.

Source:http://linkedlifedata.com/resource/pubmed/id/3528055

Download in:

View as

General Info

PMID
3528055